DEFA1 | Defensin, alpha 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA4 | Defensin, alpha 4, corticostatin | Predicted secreted proteins
| | | | | Tissue enriched |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HBD | Hemoglobin, delta | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
MMP8 | Matrix metallopeptidase 8 (neutrophil collagenase) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CAMP | Cathelicidin antimicrobial peptide | Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
RNASE2 | Ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PGLYRP1 | Peptidoglycan recognition protein 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CTSG | Cathepsin G | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PRG3 | Proteoglycan 3 | Predicted secreted proteins
| | | | | Tissue enriched |
AHSP | Alpha hemoglobin stabilizing protein | Plasma proteins
| | | | | Tissue enriched |
BPI | Bactericidal/permeability-increasing protein | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
SPTA1 | Spectrin, alpha, erythrocytic 1 (elliptocytosis 2) | Disease related genes Plasma proteins
| | | | | Tissue enriched |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
GYPA | Glycophorin A (MNS blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HEMGN | Hemogen | | | | | | Group enriched |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC4A1 | Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) | Blood group antigen proteins CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
S100A12 | S100 calcium binding protein A12 | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enriched |
CHIT1 | Chitinase 1 (chitotriosidase) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FCAR | Fc fragment of IgA, receptor for | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HIST1H1E | Histone cluster 1, H1e | Cancer-related genes
| | | | | Tissue enriched |
IFIT1B | Interferon-induced protein with tetratricopeptide repeats 1B | | | | | | Tissue enriched |
PADI4 | Peptidyl arginine deiminase, type IV | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | | | | Group enriched |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
HBQ1 | Hemoglobin, theta 1 | | | | | | Tissue enriched |
HAL | Histidine ammonia-lyase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
MFSD2B | Major facilitator superfamily domain containing 2B | Predicted membrane proteins
| | | | | Tissue enriched |
DNTT | DNA nucleotidylexotransferase | Enzymes Plasma proteins
| | | | | Tissue enriched |
HIST1H2AH | Histone cluster 1, H2ah | | | | | | Tissue enriched |
NFE2 | Nuclear factor, erythroid 2 | Transcription factors
| | | | | Tissue enriched |
SLC22A16 | Solute carrier family 22 (organic cation/carnitine transporter), member 16 | Predicted membrane proteins
| | | | | Group enriched |
HBA1 | Hemoglobin, alpha 1 | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
HIST1H2BL | Histone cluster 1, H2bl | Plasma proteins
| | | | | Tissue enriched |
NME8 | NME/NM23 family member 8 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
TMCC2 | Transmembrane and coiled-coil domain family 2 | Predicted membrane proteins
| | | | | Group enriched |
CLEC4D | C-type lectin domain family 4, member D | Predicted membrane proteins
| | | | | Group enriched |
HBA2 | Hemoglobin, alpha 2 | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
HBB | Hemoglobin, beta | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | | Group enriched |
CCNL1 | Cyclin L1 | Predicted secreted proteins
| | | | | Tissue enriched |
CDT1 | Chromatin licensing and DNA replication factor 1 | Disease related genes
| | | | | Tissue enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
H1FX | H1 histone family, member X | Plasma proteins
| | | | | Tissue enriched |
HIST1H3B | Histone cluster 1, H3b | Cancer-related genes
| | | | | Tissue enriched |
NRIP3 | Nuclear receptor interacting protein 3 | | | | | | Group enriched |
PF4 | Platelet factor 4 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |